Cargando…

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

INTRODUCTION: Breast Cancer Index (BCI) combines two independent biomarkers, HOXB13:IL17BR (H:I) and the 5-gene molecular grade index (MGI), that assess estrogen-mediated signalling and tumor grade, respectively. BCI stratifies early-stage estrogen-receptor positive (ER+), lymph-node negative (LN-)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jankowitz, Rachel C, Cooper, Kristine, Erlander, Mark G, Ma, Xiao-Jun, Kesty, Nicole C, Li, Hongying, Chivukula, Mamatha, Brufsky, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262211/ https://www.ncbi.nlm.nih.gov/pubmed/21999244 http://dx.doi.org/10.1186/bcr3038

Ejemplares similares

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term
por: Jankowitz, Rachel C, et al.
Publicado: (2012)

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
por: Jerevall, P-L, et al.
Publicado: (2011)

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
por: Lambertini, Matteo, et al.
Publicado: (2016)

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer
por: Foldi, Julia, et al.
Publicado: (2023)

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study
por: Sgroi, Dennis C., et al.
Publicado: (2016)

Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology
por: Blohmer, Martin, et al.
Publicado: (2020)

Gene expression profiling of the tumor microenvironment during breast cancer progression
por: Ma, Xiao-Jun, et al.
Publicado: (2009)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021)

The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-stage Breast Cancer Patients
por: Rejali, Mehri, et al.
Publicado: (2015)

Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
por: Schroeder, Brock, et al.
Publicado: (2017)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

Epigenetics in breast cancer: what's new?
por: Huang, Yi, et al.
Publicado: (2011)

Editorial: BRCA1 and BRCA2 gene mutations screening in sporadic breast cancer patients in Kazakhstan
por: Jankowitz, Rachel C., et al.
Publicado: (2013)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Adjuvant! Online or comprehensive geriatric assessment for women over 70 years with primary breast cancer?
por: Monfardini, S, et al.
Publicado: (2012)

Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer
por: Koleck, Theresa A., et al.
Publicado: (2017)

Artificial intelligence-directed prognostication of breast cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2019)

nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings
por: Brufsky, Adam
Publicado: (2017)

External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement
por: Hajage, David, et al.
Publicado: (2011)

Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience
por: Hearne, Benjamin Joseph, et al.
Publicado: (2015)

Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2013)

HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
por: Habel, Laurel A, et al.
Publicado: (2013)

Current Approaches and Emerging Directions in HER2-resistant Breast Cancer
por: Brufsky, Adam M
Publicado: (2014)

Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria
por: Jahn, B., et al.
Publicado: (2015)

Prospects of adjuvant RANKL inhibition in breast cancer?
por: Rachner, T D, et al.
Publicado: (2015)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Puhalla, Shannon, et al.
Publicado: (2008)

Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer
por: Wu, Shandong, et al.
Publicado: (2016)

Accuracy validation of adjuvant! online in Taiwanese breast cancer patients - a 10-year analysis
por: Yao-Lung, Kuo, et al.
Publicado: (2012)

Statins and endocrine resistance in breast cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions
por: Hough, Bruce, et al.
Publicado: (2010)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

Metformin as an adjuvant in breast cancer treatment
por: Roshan, Mohsin HK, et al.
Publicado: (2019)

Patient preferences for chemotherapies used in breast cancer
por: Beusterien, Kathleen, et al.
Publicado: (2012)

Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial
por: Bartlett, J M S, et al.
Publicado: (2019)

Statin drugs to reduce breast cancer recurrence and mortality
por: Beckwitt, Colin H., et al.
Publicado: (2018)

Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.
Publicado: (1988)

Serous fluid: Metastatic sarcomas, melanoma, and other non-epithelial neoplasms
por: Pantanowitz, Liron, et al.
Publicado: (2022)

Adjuvant tamoxifen for male breast cancer (MBC).
por: Ribeiro, G., et al.
Publicado: (1992)

Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
por: Ismaili, Nabil, et al.
Publicado: (2009)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gnc9ir0mkatmer7keldm8qvei5